Please login to the form below

Not currently logged in
Email:
Password:

ARX-115

This page shows the latest ARX-115 news and features for those working in and with pharma, biotech and healthcare.

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

AbbVie to develop argenx-partnered GARP-targeted immunotherapy

The biotech can also co-promote ARGX-115-based products in the EU and Swiss Economic Area if it wishes. ... β). The companies have said that ARGX-115 will selectively limit the activity of activated regulatory T-cells (Tregs).

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics